 |
 |

Use of -Glutamyl Transpeptidase in the Diagnosis of Biliary Atresia
Kelly Wright, MD;
Dennis L. Christie, MD
Am J Dis Child. 1981;135(2):134-136.
Abstract
A simple, nonsurgical means of differentiating biliary atresia (BA) from neonatal hepatitis has remained elusive. To determine its diagnostic usefulness, serum -glutamyl transpeptidase (GGTP) levels were measured prospectively in 17 infants (aged 5 to 16 weeks) admitted consecutively to rule out BA. Seven patients were found to have BA, seven had neonatal hepatitis (NH), and three had 1-antitrypsin (A1A) deficiency. The mean maximal GGTP level in those patients with NH (183 ± 54 IU/L) was significantly lower than that found in patients with BA (760 ± 492 IU/L) or A1A deficiency (1,725 ± 921 IU/L). In the 14 patients without A1A deficiency, a serum GGTP level greater than 300 IU/L correctly identified six of seven patients with BA, while a GGTP level less than 300 IU/L correctly identified seven of seven patients with NH, although including one false-negative finding, in a patient with choledochal cyst and BA.
(Am J Dis Child 1981;135:134-136)
Author Affiliations
From the Division of Neonatal Biology, Department of Pediatrics, University of Washington, Seattle (Dr Wright); and the Division of Pediatric Gastroenterology, Children's Orthopedic Hospital and Medical Center, Seattle (Dr Christie).
Footnotes
Reprint requests to Division of Neonatal Biology, Department of Pediatrics, RD-20, University of Washington, 1959 NE Pacific, Seattle, WA 98195 (Dr Wright).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
|